TERN insider transactions

SEC Form 4 filed by Kuriakose Emil

Chief Executive Officer Burroughs Amy L. exercised 14,583 shares at a strike of $4.64 and sold $681,108 worth of shares (14,583 units at $46.71) (SEC Form 4)

Chief Executive Officer Burroughs Amy L. exercised 14,583 shares at a strike of $4.64 and sold $571,579 worth of shares (14,583 units at $39.19) (SEC Form 4)

SEC Form 4 filed by Director Turner Heather D

SEC Form 4 filed by Director Tripuraneni Radhika

SEC Form 4 filed by Director Azelby Robert

SEC Form 4 filed by Director Quigley Jill M.

SEC Form 4 filed by Director Kindler Jeffrey B

SEC Form 4 filed by Director Fellows David A

Chief Medical Officer Kuriakose Emil was granted 56,250 shares, increasing direct ownership by 112% to 106,615 units (SEC Form 4)

Chief Financial Officer Gengos Andrew was granted 68,750 shares, increasing direct ownership by 208% to 101,788 units (SEC Form 4)

Chief Executive Officer Burroughs Amy L. sold $2,548,603 worth of shares (68,749 units at $37.07), was granted 150,000 shares and exercised 68,749 shares at a strike of $4.64, increasing direct ownership by 108% to 288,976 units (SEC Form 4)

Chief Executive Officer Burroughs Amy L. sold $2,718,230 worth of shares (71,339 units at $38.10) and exercised 171,551 shares at a strike of $0.58, increasing direct ownership by 259% to 138,976 units (SEC Form 4)

Chief Medical Officer Kuriakose Emil sold $44,552 worth of shares (1,155 units at $38.57), decreasing direct ownership by 2% to 50,365 units (SEC Form 4)

Director Quigley Jill M. exercised 24,520 shares at a strike of $9.24 and sold $441,360 worth of shares (24,520 units at $18.00) (SEC Form 4)

Chief Medical Officer Kuriakose Emil sold $7,407 worth of shares (944 units at $7.85), decreasing direct ownership by 2% to 51,520 units (SEC Form 4)

Chief Medical Officer Kuriakose Emil sold $3,640 worth of shares (853 units at $4.27), decreasing direct ownership by 2% to 52,464 units (SEC Form 4)

Chief Financial Officer Gengos Andrew bought $39,283 worth of shares (10,000 units at $3.93), increasing direct ownership by 67% to 25,000 units (SEC Form 4)

Chief Executive Officer Burroughs Amy L. bought $90,230 worth of shares (23,314 units at $3.87), increasing direct ownership by 98% to 47,083 units (SEC Form 4)

Chief Financial Officer Gengos Andrew bought $57,082 worth of shares (15,000 units at $3.81) (SEC Form 4)

SEC Form 4 filed by Director Tripuraneni Radhika

SEC Form 4 filed by Director Lu Hongbo

SEC Form 4 filed by Director Kindler Jeffrey B

SEC Form 4 filed by Director Turner Heather D

SEC Form 4 filed by Director Quigley Jill M.

SEC Form 4 filed by Director Fellows David A

Chief Medical Officer Kuriakose Emil sold $2,366 worth of shares (952 units at $2.49), decreasing direct ownership by 2% to 53,317 units (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Gengos Andrew

SEC Form 3 filed by new insider Gengos Andrew

SEC Form 4 filed by Director Azelby Robert

SEC Form 3 filed by new insider Azelby Robert

New insider Strauss David Eric claimed ownership of 89,673 shares (SEC Form 3)

SEC Form 4 filed by Director Lu Hongbo

SEC Form 4 filed by Director Tripuraneni Radhika

SEC Form 4 filed by Director Quigley Jill M.

SEC Form 4 filed by Director Kindler Jeffrey B

SEC Form 4 filed by Director Fellows David A

Chief Business Officer Jung Melita Sun bought $11,498 worth of shares (2,250 units at $5.11) (SEC Form 4)

SEC Form 4 filed by Chief Medical Officer Kuriakose Emil

Chief Executive Officer Burroughs Amy L. bought $2,606 worth of shares (510 units at $5.11), increasing direct ownership by 3% to 19,609 units (SEC Form 4)

Director Quigley Jill M. sold $86,460 worth of shares (15,000 units at $5.76), closing all direct ownership in the company (SEC Form 4)

Chief Medical Officer Kuriakose Emil sold $25,607 worth of shares (4,481 units at $5.71), decreasing direct ownership by 8% to 54,269 units (SEC Form 4)

Chief Financial Officer Vignola Mark J. sold $99,024 worth of shares (17,188 units at $5.76), decreasing direct ownership by 19% to 74,752 units (SEC Form 4)

SEC Form 4 filed by Chief Medical Officer Kuriakose Emil

Chief Executive Officer Burroughs Amy L. bought $110,468 worth of shares (15,450 units at $7.15), increasing direct ownership by 423% to 19,099 units (SEC Form 4)

SEC Form 4 filed by Director Turner Heather D

SEC Form 3 filed by new insider Turner Heather D

Director Lu Hongbo bought $4,999,995 worth of shares (476,190 units at $10.50) (SEC Form 4)

Chief Financial Officer Vignola Mark J. exercised 10,000 shares at a strike of $5.36 and sold $110,000 worth of shares (10,000 units at $11.00) (SEC Form 4)

Director Quigley Jill M. exercised 17,235 shares at a strike of $1.82 and sold $172,350 worth of shares (17,235 units at $10.00) (SEC Form 4)

Director Quigley Jill M. sold $113,580 worth of shares (15,000 units at $7.57), decreasing direct ownership by 50% to 15,000 units (SEC Form 4)

Director Gordon Carl L sold $561,640 worth of shares (56,164 units at $10.00) (SEC Form 4)

Director Orbimed Advisors Llc sold $561,640 worth of shares (56,164 units at $10.00) (SEC Form 4)

Director Quigley Jill M. exercised 14,765 shares at a strike of $1.82 and sold $147,660 worth of shares (14,765 units at $10.00) (SEC Form 4)

SEC Form 4 filed by Director Tripuraneni Radhika

SEC Form 4 filed by Director Taylor Ann Elizabeth

SEC Form 4 filed by Director Lu Hongbo

SEC Form 4 filed by Director Kindler Jeffrey B

SEC Form 4 filed by Director Gordon Carl L

SEC Form 4 filed by Director Fellows David A